Tissue Diagnostic Market analysis, Segment, Trends and Forecasts, 2022: Grand View Research, IncMedical Records ManagementUpdated on May 13, 2015 View more like this | Visit SAN FRANCISCO, CA | Contact Andrew Smith |
Tissue diagnostic procedures encompass a broad array of technologies designed to revolutionize the cancer diagnosis process and provide apt molecular information. Tissue diagnostic detects the presence of malignant cells by performing microscopic study of the involved tissue. This investigation is considered to be vital for any type of cancer in order to decide the most effective treatment line.
To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/tissue-diagnostics-market
Further key findings from the study suggest:
Immunohistochemistry (IHC) is identified as the most lucrative sub segment of the tissue diagnostic market majorly owing to increasing incidences of cancer diagnostic
The tissue based breast cancer diagnostic segment accounted for the largest market share in 2014. Rising alcohol consumption, lifestyle associated changes and growing geriatric population are some factors expected to drive segment growth over the forecast period.
North America accounted for over 40.0% of the tissue diagnostic market in 2014 on account of high usage rates of technologically advanced products. Rising patient awareness level and the presence of accessible healthcare infrastructure is also expected to contribute towards healthy regional market growth.
To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/tissue-diagnostics-market
Further key findings from the study suggest:
Immunohistochemistry (IHC) is identified as the most lucrative sub segment of the tissue diagnostic market majorly owing to increasing incidences of cancer diagnostic
The tissue based breast cancer diagnostic segment accounted for the largest market share in 2014. Rising alcohol consumption, lifestyle associated changes and growing geriatric population are some factors expected to drive segment growth over the forecast period.
North America accounted for over 40.0% of the tissue diagnostic market in 2014 on account of high usage rates of technologically advanced products. Rising patient awareness level and the presence of accessible healthcare infrastructure is also expected to contribute towards healthy regional market growth.
